T he failing myocardium from humans and experimental animals commonly shows increased expression of the receptors for the Ca 2+ -regulating second messenger inositol (1, 4, 5) -trisphosphate (Ins(1,4,5)P 3 [IP 3 ]) receptors (IP 3 -R), often along with a decrease in ryanodine receptors, the master regulators of Ca 2+ within the myocardium. 1 The importance, or otherwise, of this has been debated. The altered relative expression levels of the intracellular Ca 2+ channels might reflect a degree of dedifferentiation of the failing ventricular myocytes, with no major functional implications. Alternatively, increased IP 3 -R might contribute to, or ameliorate, the progression of heart failure. IP 3 -R have been suggested to contribute to cardiomyocyte hypertrophy, 2,3 chamber dilatation, 4 and arrhythmogenesis, 5 but there is little agreement between laboratories in relation to any of these claims.
Clinical Perspective on p 325
Under physiological conditions, cardiomyocytes from all species studied show little or no change in Ins (1, 4, 5) P 3 in response to the activation of appropriately coupled receptors, 6 and, in addition, the expression of IP 3 -R is low. 7 These findings argue against a strong involvement of IP 3 -R under physiological conditions. However, our earlier and recent studies show that generation of Ins(1,4,5)P 3 is markedly heightened under pathological conditions such as atrial dilatation in humans, mice with dilated cardiomyopathy (DCM), 4 and in hypertrophied mouse ventricle after chronic pressure overload. 8 Furthermore, we have observed heightened expression of phospholipase Cβ1b, the enzyme responsible for generation of Ins(1,4,5)P 3 in myocytes, from failing human, mouse, and sheep myocardium 4 (sheep data not shown). All these findings suggest that Ins (1, 4, 5 )P 3 may be of heightened importance in failing myocardium, especially given the likelihood of increased IP 3 -R expression. 7, 9 We undertook an investigation of the possible pathological roles of IP 3 -R using a mouse model with severe DCM and clear evidence of conduction block (DCM-2Tg), as well as a well-characterized model of pressure overload hypertrophy, induced by transverse aortic constriction (TAC). 8 Both of these murine model show increased generation of Ins (1, 4, 5) P 3 4,8 and increased expression of type 2 IP 3 -R (IP 3 -R(2)), the IP 3 -R subtype expressed in working cardiomyocytes. To examine possible contributions of the heightened Ins(1,4,5) P 3 and IP 3 -R(2) to hypertrophy and dilatation, we performed TAC on IP 3 -R(2)−/− mice and crossed the DCM-2Tg with IP 3 -R(2)−/− mice and examined the effect on progression of disease in both scenarios.
Methods

Experimental Animals
All experiments were approved by the Alfred Medical Research and Education Precinct Animal Ethics Committee.
DCM-2Tg Model
Cardiac-specific Mst1 (line no. 28; C57BL/6 background) and dn-PI3K (FVB/N) transgenic mice were generated and genotyped as described previously. 10,11 IP 3 -R(2)−/− mice were generated on a C57BL6 background, as described. 5 Male heterozygous Mst1-Tg (Mst1 +/− ) were genetically crossed with dnPI3K +/− and IP 3 -R(2)−/− to generate DCM-2Tg mice (Mst1 +/− dnPI3K +/− , Mst1×dnPI3K-2Tg, DCM-2Tg) and DCM-2Tg-knockout mice (Mst1 +/− /dnPI3K +/− /IP 3 -R(2)−/−). 12 The crossed strain (Mst1×dnPI3K2-Tg) was chosen for these studies because, unlike the Mst1-Tg, they show severe conduction block and we were interested in possible atrial actions of IP 3 -R(2). All mice were bred on the same mixed genetic background (C57BL/6/FVB/N).
Transverse Aortic Constriction
Two-month-old male mice were anesthetized with ketamine/xylazine and underwent a sham operation or were subjected to pressure overload induced by TAC as previously described. 13 Echocardiography measurements were performed before surgery and at 1 and 4 weeks after TAC. The pressure gradients generated by aortic banding were measured by introducing high-fidelity pressure transducers into the left and right common carotids. Pressure gradients in IP 3 -R(2)−/− and wild-type (WT) littermates were similar ( Figure IA in the online-only Data Supplement). Hearts were collected and morphometrics evaluated 4 weeks post-TAC.
Transthoracic Echocardiography and Electrocardiography
Anesthesia was maintained with 1.7% isoflurane. Echocardiography was performed using a Philips iE33 ultrasound machine and a 15-MHz linear transducer. Electrocardiography (ECG) recordings were measured using the Powerlab System and BioAmp (ADInstruments). Data were measured digitally using ADInstruments (Chart 5 Pro ECG analysis module). Details are provided in the online-only Data Supplement.
Measurement of Ins(1,4,5)P 3 and Its Metabolites in Atria and Ventricles (Phospholipase C Activation)
Tissues were labeled with [ 3 H]inositol and subsequently stimulated with norepinephrine (50 µmol/L). [ 3 H]Ins(1,4,5)P 3 and its metabolites were extracted and quantified by high-performance liquid chromatography, as described previously. 4, 14 Details are provided in the online-only Data Supplement.
Measurement of mRNA and Protein Expression in Atria and Ventricles
RNA was extracted using RNEasy kits from Qiagen or Trizol reagent (Invitrogen) according to the manufacturer's instructions and reverse transcribed using Superscript III (Invitrogen). Quantitative real-time polymerase chain reaction with SybrGreen (Invitrogen) reagent was performed on an Applied Biosciences 7500 Fast Real-Time PCR System. Primer sequences are provided in the online-only Data Supplement. Values are expressed as the 2 −ΔCt value relative to GAPDH in each sample. 15 All quantitative real-time polymerase chain reaction experiments were performed in triplicate on triplicate or quadruplicate samples. RNA dot-blot analyses were performed as previously described. 16 Protein methods are outlined in the onlineonly Data Supplement.
Data Evaluation
For experiments involving 2 groups (WT and DCM or sham and TAC), or where n=3, data were analyzed using a Mann-Whitney rank-sum test. For experiments involving 4 groups (WT, IP 3 -R(2)−/−, DCM, DCM×IP 3 -R(2)−/− or Sham, sh. IP 3 -R(2)−/−, TAC, TAC IP 3 -R(2)−/−), a 2-way ANOVA was used to assess the effect of TAC or DCM, the IP 3 -R(2) status, and the interaction between the 2 (Sigma Stat). Where repeated measures were involved (echo measurements after TAC), a repeated measures 2-way ANOVA was used. All pairwise multiple comparisons used a Holm-Sidak post hoc test, except where normality tests failed and a rank-sum test was used (Sigma Stat).
Results
Hearts From DCM-2Tg Mice or TAC Mice Have Heightened Expression of IP 3 -R(2) and Heightened Generation of Ins(1,4,5)P 3
The IP 3 -R(2) is expressed in working cardiomyocytes, and we measured expression in hearts from DCM-2Tg mice that have DCM, as well as from mice that have undergone TAC to induce pressure overload hypertrophy. The DCM-2Tg mice had heightened in IP 3 -R(2) expression in atria and left ventricles ( Figure 1A ). Loss of IP 3 -R(2) in IP 3 -R(2)−/− mice did not result in altered expression of either of the other IP 3 -R subtypes, IP 3 -R(1) or IP 3 -R(3) ( Figure I in the online-only Data Supplement). IP 3 -R(2) expression also was substantially elevated 4 weeks after TAC ( Figure 1B and 1C).
We have previously reported that TAC-induced hypertrophy leads to heightened InsP responses in mouse hearts, resulting in increased generation of Ins(1,4,5)P 3 . 8 In the current study, we assessed Ins(1,4,5)P 3 generation in atria and ventricles from DCM-2Tg and littermate WT mice. This was accomplished by labeling the inositol phospholipids with [ 3 H]inositol and subsequently measuring the generation of [ 3 H]-labeled Ins(1,4,5)P 3 and its metabolites as a measure of total [ 3 H]Ins(1,4,5)P 3 generation. As described previously, 4 atria and ventricles from WT mice have low levels of [ 3 H]InsPs after 20 minutes of treatment with norepinephrine (50 µmol/L), indicating minimal generation of Ins(1,4,5)P 3 . Responses were substantially heightened in atria and ventricles from DCM-2Tg mice, reflecting increased Ins(1,4,5)P 3 production ( Figure 1D ).
Deletion of IP 3 -R(2) Does Not Influence Heart Size in DCM-2Tg Mice or TAC Mice
DCM-2Tg mice develop DCM, indicated by chamber dilatation, left ventricular wall thinning, and decreased contractile function. 12 We argued that heightened generation of Ins(1,4,5)P 3 , together with heightened expression of IP 3 -R(2), might contribute substantially to the DCM phenotype in these animals. To test this possibility, we examined the phenotype of the DCM-2Tg mice in which IP 3 -R(2) had been deleted (DCM-2Tg×IP 3 -R(2)−/−) and compared this with DCM mice expressing the endogenous complement of IP 3 -R(2) (DCM-2Tg). As reported previously, 12 DCM mice exhibited severe left ventricular dilatation ( Figure IIB in the online-only Data Supplement and Table 1 ), increased atrial size, and ventricular wall thinning compared with WT mice (Table 1 ). There was no hypertrophy observed in the DCM-2Tg hearts. DCM-2Tg mice with IP 3 -R(2) deleted showed a phenotype indistinguishable from that of DCM-2Tg mice (Tables 1 and 2) .
In contrast to the DCM-2Tg model, mice subjected to TAC develop ventricular hypertrophy indicated by increased left ventricle/body weight ratio and increased ventricular wall thickness. Deletion of IP 3 -R(2) did not alter the cardiac phenotype either in TAC mice or in sham-operated controls. Measurements were made both early (1 week) and late (4 weeks after TAC), and no effect of IP 3 -R(2) deletion was observed at either time point ( Figure 2 ).
Deletion of IP 3 -R(2) Does Not Alter Gene Expression Profiles in DCM-2Tg Mice or TAC Mice
DCM-2Tg mice show alterations in ventricular gene expression, reflecting disease progression. 12 We examined transcriptional responses in DCM mice with and without their complement of IP 3 -R(2). As shown in Figure 3A , DCM in the DCM-2Tg was associated with increased expression of atrial natriuretic peptide and α-skeletal actin. Deletion of IP 3 -R(2) did not alter these expression changes. As reported previously, 8 TAC induced changes in hypertrophic gene expression profiles, atrial natriuretic peptide, α-myosin heavy chain, β-myosin heavy chain, and α-skeletal actin, and these were not altered by deletion of IP 3 -R(2) ( Figure 3C and 3D).
Ins(1,4,5)P 3 /IP 3 -R(2) signaling has been suggested to contribute to hypertrophy by generating the Ca 2+ required to activate calcineurin, which in turn dephosphorylates the nuclear factor of activated T cells family of transcription factors culminating in altered gene expression profiles. 17 Calcineurin is known to be activated by TAC, and we examined whether deletion of IP 3 -R(2) altered calcineurin signaling after TAC. Modulatory calcineurin-interacting protein is a direct transcriptional target of calcineurin, and we measured modulatory calcineurin-interacting protein as an index of calcineurin signaling. As shown in Figure 3B , modulatory calcineurin-interacting protein expression was increased at 4 weeks after TAC, but deletion of IP 3 -R(2) did not influence expression either in TAC or in sham-operated mice.
Table 1. Echocardiographic Parameters in DCM-2Tg mice and the Effect of Deletion of IP 3 -R(2)
WT (7) IP 3 -R(2)−/− (5) DCM-2Tg (6) DCM-2Tg×IP 3 -R(2)−/− (12) P P P DCM IP 3 -R(2)−/− Int.
Deletion of IP 3 -R(2) Does Not Alter ECG Profiles in DCM-2Tg Mice
We next examined whether deletion of IP 3 -R(2) influenced electrophysiological changes that we have previously found to be associated with heart failure in the DCM model. 12 No arrhythmias were observed over the time periods studied. Relative to WT littermates, ECG profiles from DCM-2Tg mice showed prolonged P-R interval, prolonged Q-T interval, and reduced R amplitude. R-R interval, QRS interval, and ST height were not significantly altered in the DCM mice. Deletion of IP 3 -R(2) did not influence these changes, and data obtained from DCM-2Tg and DCM-2Tg×IP 3 -R(2)−/− were not different in terms of any of these parameters. Deletion of IP 3 -R(2) also did not alter ECG profiles in the absence of DCM ( Figure IIC in the online-only Data Supplement and Table 3 ).
Deletion of IP 3 -R(2) Does Not Alter Functional Parameters in DCM-2Tg Mice or in TAC Mice
DCM-2Tg mice die prematurely by 10 to 12 weeks of age. Deletion of IP 3 -R(2) did not alter the death rate in this strain ( Figure 4A ). DCM-2Tg mice showed a high incidence of pleural effusion, lung congestion, and atrial thrombus, consistent with severe heart failure. Deletion of IP 3 -R(2) did not alter any of these parameters ( Figure 4B ). Contractility, measured as fractional shortening by echocardiography, was substantially reduced in the DCM-2Tg mice, but was not influenced by deletion of IP 3 -R(2) ( Figure 4C and Table 1 ). Lung congestion was similar in DCM-2Tg mice with and without their complement of IP 3 -R(2) ( Figure 4D ). Thus, IP 3 -R(2) do not contribute substantially to the heart failure phenotype in this model. TAC resulted in a progressive decrease in fractional shortening that was not altered by IP 3 -R(2) deletion ( Figure 4E) . Similarly, increases in left ventricular weight were similar in WT and IP 3 -R(2)−/− mice after TAC ( Figure 4F ).
Discussion
Heart failure in humans and experimental animals has repeatedly been reported to be associated with increased ventricular expression of IP 3 -R(2) in the left ventricle. 7, 18, 19 Increased atrial expression has been reported in valvular heart disease and atrial fibrillation. 9 Furthermore, increased IP 3 -R(2) expression has been reported in neonatal rat cardiomyocytes undergoing hypertrophy. 2 In some cases, the increased IP 3 -R(2) expression is paralleled by a lowering of ryanodine receptor expression. 7, 18 These findings might suggest that IP 3 -R(2) are of increased importance in hypertrophic and failing myocardium. It has been suggested that the increased IP 3 -R activity Table 2 
. Morphometric Parameters in DCM-2Tg Mice and the Effect of Deletion of IP 3 -R(2)
WT (6) IP 3 contributes to pathology by promoting hypertrophic growth of the cardiomyocytes 3, 20 or that the increased IP 3 -R might contribute to arrhythmia by perturbing Ca 2+ responses close to sarcolemmal Ca 2+ channels and the Na + /Ca 2+ exchanger. 5, 21 Alternatively, the changes might reflect a loss of muscle phenotype because the cardiomyocytes undergo the transition to failure and have little functional consequence. We recently reported that dilated atrial tissues from patients with valvular heart disease have substantially heightened generation of Ins(1,4,5)P 3 and, furthermore, that generation correlated with atrial volume, suggesting a relationship to atrial dilatation. Similar observations were made in the dilated atria from hearts of mice overexpressing Mst1, where phospholipase C activity correlated with atrial weight. 4 Transgenic mice expressing Mst1 in heart have been previously reported to have DCM, 10 and the phenotype is exacerbated by coexpression of dominant-negative PI3kinase. 12 The crossed strain (Mst1×dn-PI3K-2Tg; DCM-2Tg) has a worsened heart failure phenotype compared with Mst1-Tg and, in addition, shows clear evidence of conduction block, reflected by increased P-R interval 12 (Table 3 ). Both the Mst1-Tg and Mst1×dn-PI3K-2Tg strains express heightened levels of IP 3 -R(2) in atria and ventricles, and additionally both have substantially increased Ins(1,4,5)P 3 generation (Figure 1 ). 4 We reasoned that the heightened Ins(1,4,5)P 3 /IP 3 -R axis in this mouse strain provided an excellent opportunity to evaluate its contribution to the DCM phenotype. The crossed strain (Mst1×dn-PI3K-2Tg; DCM-2Tg) was chosen for these studies because we were interested in a possible contribution of Ins(1,4,5)P 3 and IP 3 -R(2) to conduction block, as well as to chamber dilatation and heart failure. The DCM model involves chamber dilatation, possibly related to enhanced cardiomyocyte apoptosis, without cardiomyocyte hypertrophy. 10 In addition to a contribution to heart failure, IP 3 -R have been suggested to contribute to hypertrophic signaling pathways by supplying Ca 2+ to activate the calcineurin/nuclear factor of activated T cells (NFAT) pathway 3 or by activating calcium calmodulindependent protein kinase II (CaMKII) localized close to the nuclear membrane. 20 To evaluate possible contributions of the Ins(1,4,5)P 3 /IP 3 -R(2) axis to hypertrophy, we used a wellestablished pressure overload model. 22 When we compared the DCM-2Tg mice with DCM-2Tg mice lacking IP 3 -R(2), we found no difference in the extent of dilatation, chamber size, or contractile dysfunction. Indices of heart failure, lung congestion, atrial thrombus, and pleural effusion also were similar between the 2 experimental groups. Life span also was similar in the 2 groups ( Figure 4A ), showing that elimination of IP 3 -R(2) did not slow disease progression. ECG studies on DCM mice revealed increased P-R interval indicative of conduction block and long Q-T interval, reflecting prolonged action potential duration. Neither of these perturbations was altered by deletion of IP 3 -R(2) ( Table  3) . Hypertrophic responses to pressure overload also were not altered by removal of IP 3 -R(2). At either 1 week or 4 weeks after TAC, WT and IP 3 -R(2)−/− mice showed similar changes in ventricular dimensions and ventricular weight (Figures 2  and 4F ). Failure to detect any effect of deleting IP 3 -R(2) on any of the pathological changes observed in either DCM-2Tg mice or mice subjected to TAC argues strongly that Ins(1,4,5) P 3 and its receptors do not make a major contribution, either positively or negatively, to hypertrophy, chamber dilatation, or conduction block in these models.
Heightened IP 3 -R expression has been a common finding in a range of cardiac pathologies. Heightened left ventricular expression has been reported in failing human heart, 1,23 in a rabbit model of nonischemic heart failure, 18 as well as in the murine DCM model used in this study and after TAC (Figure 1) . IP 3 -R expression/activity is also increased in atrial tissue from patients with atrial fibrillation associated with valvular heart disease. 9, 24 In the latter study, the increased IP 3 -R expression reversed after cardioversion to sinus rhythm, suggesting a contribution of IP 3 -R to AF in this patient group. However, the expression of several ion channels and transporters showed a similar reversion with return to sinus rhythm, and the observed changes might be a consequence of, rather than a contributor to AF, as suggested by another study. 25 In contrast to IP 3 -R expression studies, assessment of changes in the generation of Ins(1,4,5)P 3 in heart disease states has been limited. Our previous studies have shown increased generation of Ins(1,4,5)P 3 in atrial tissue from patients with valve disease, in hypertrophied ventricle from mice after chronic pressure overload, in atria and ventricles of the murine DCM model, and in rodent hearts subjected to acute ischemia/ reperfusion. 4, 8, [26] [27] [28] Other laboratories have also reported heightened Ins(1,4,5)P 3 generation in hearts undergoing hypertrophy 29 or after ischemia or ischemia/reperfusion. [30] [31] [32] Thus, heightened generation of Ins(1,4,5)P 3, like increased IP 3 -R expression, may be a common feature in cardiac pathologies. It is important to note that production of Ins(1,4,5) P 3 is an indication of phospholipase C activation after receptor activation. Ins(1,4,5)P 3 is generated from the sarcolemmal phospholipid phosphatidylinositol(4,5)-bisphosphate along with sn-1,2-diacylglycerol. Thus, increases in Ins(1,4,5) P 3 indicate increased sn-1,2-diacylglycerol generation to activate subtypes of protein kinase C and protein kinase D, 33, 34 as well as some sarcolemmal canonical transient receptor potential channels. 35 Any of these sn-1,2-diacylglycerolinduced responses could have major influences on disease progression that are independent of IP 3 -R. Changes in the precursor phosphatidylinositol(4,5)-bisphosphate also may be of critical significance, because this lipid is a direct regulator of the activity of a range of sarcolemmal ion channels critical in the maintenance of cardiac rhythm. [35] [36] [37] [38] It is also possible that Ins(1,4,5)P 3 has functions other than those that require IP 3 -R activation. Ins(1,4,5)P 3 is the precursor of the highly phosphorylated inositol derivatives (InsP4-InsP8), 39, 40 some of which are known to be functionally important, 41 but currently such functions have not been described in heart.
These studies show that IP 3 -R(2) do not make a significant contribution to disease in the DCM-2Tg or TAC models, despite the increased activity of the Ins(1,4,5)P 3 /IP 3 -R(2) axis. We have recently reported that IP 3 -R(2) contribute to the regulation of pacemaker function in mice by demonstrating a lowering of the Ca 2+ responses (by ≈12%) in isolated sinoatrial node tissue in IP 3 -R(2)−/− mice. 21 In the current study, we did not detect any effect of deletion of IP 3 -R(2) on heart rate in DCM-2Tg mice, TAC mice, or in WT or sham-operated littermates. However, this contribution of IP 3 -R(2) to pacemaker activity would be expected to be buffered by the autonomic nervous system in in vivo studies.
In conclusion, we have demonstrated that Ins(1,4,5)P 3 and its receptors do not contribute to disease in murine models of DCM and hypertrophy, both of which have heightened Ins(1,4,5)P 3 generation and increased IP 3 -R(2) expression. This finding shows that heightened expression of IP 3 -R in heart disease cannot be assumed to have functional significance.
